BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11459286)

  • 1. Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas.
    Chan CC; Menges M; Orzechowski HD; Orendain N; Pistorius G; Feifel G; Zeitz M; Stallmach A
    Int J Colorectal Dis; 2001 Jun; 16(3):133-40. PubMed ID: 11459286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA; Bergin FG; Leaper DJ
    Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis.
    Li BH; Zhao P; Liu SZ; Yu YM; Han M; Wen JK
    World J Gastroenterol; 2005 May; 11(20):3046-50. PubMed ID: 15918187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.
    Groblewska M; Mroczko B; Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kędra B; Kemona A; Szmitkowski M
    Tumour Biol; 2014 Apr; 35(4):3793-802. PubMed ID: 24395652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.
    Hilska M; Roberts PJ; Collan YU; Laine VJ; Kössi J; Hirsimäki P; Rahkonen O; Laato M
    Int J Cancer; 2007 Aug; 121(4):714-23. PubMed ID: 17455256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H; Ohgi S; Terada T
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Nesland JM; Berner A; Bryne M; Reich R
    Clin Exp Metastasis; 1999; 17(10):799-808. PubMed ID: 11089877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
    Zeng ZS; Guillem JG
    Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium.
    Ornstein DL; Cohn KH
    Dig Dis Sci; 2002 Aug; 47(8):1821-30. PubMed ID: 12184536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
    Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
    J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
    Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
    Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
    Schwandner O; Schlamp A; Broll R; Bruch HP
    Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression.
    Ara T; Kusafuka T; Inoue M; Kuroda S; Fukuzawa M; Okada A
    J Pediatr Surg; 2000 Mar; 35(3):432-7. PubMed ID: 10726683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
    Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
    Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.